Zosano Pharma Corporation (ZSAN)

$0.5576

0.00 (0.00%)
Rating:
Recommendation:
Buy
Symbol ZSAN
Price $0.5576
Beta 3.285
Volume Avg. 5.36M
Market Cap 65.990M
Shares () -
52 Week Range 0.1129-7.630114
1y Target Est -
DCF Unlevered ZSAN DCF ->
DCF Levered ZSAN LDCF ->
ROE -172.07% Strong Sell
ROA -208.70% Strong Sell
Operating Margin -
Debt / Equity 88.18% Buy
P/E -
P/B 0.17 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ZSAN news


Steven Lo
Healthcare
Biotechnology
NASDAQ Capital Market

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.